Info
Advanced Nanomaterials in Biomedical Application
| Advanced Nanomaterials in Biomedical Application |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2023 |
| Descrizione fisica | 1 online resource (360 p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
active targeting
adjuvants amino functionalization anti-inflammatory antibacterial effect antimicrobial antimicrobial activity bacillus subtilis bioactive glass nanoparticles biocompatibility bone regeneration breast cancer Candida albicans cell labelling cell tracking cell uptake chlorhexidine cisplatin colorimetric discrimination compressive strength controlled drug delivery coronaviruses CXC chemokine receptor 4 diagnostic nanoparticles drug delivery drug delivery systems dual-crosslinked hydrogel electrospun fibrous materials Escherichia coli fluorination FMD virus-like particles giant polyoxometalate glass ionomer cements glioblastoma glycol chitosan graphene oxide graphene oxide composites hemin HPV capsid protein hypochromic of molybdate clusters immune responses infection inflammation intestinal epithelial permeability linkers liposome magnetic nanoparticles microhardness mucus layers multidrug-resistant bacteria n/a nano-emulsion nanomaterials nanomedicine nanoparticles nanosilica nanotubes opposite color response oral drug delivery systems osmoregulatory peptide osteoimmunomodulation osteosarcoma passive targeting phenolic acid platinum-based drug platinum(IV) conjugates PLGA nanoparticles poly-3-hydroxybutyrate polyethylene glycol polyethyleneimine RNA interference silver nanoparticles squalane stem cell homing strength and elasticity targeted drug delivery targeting nanoparticles vaccines β-glucan |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910743281603321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
MERS-CoV
| MERS-CoV |
| Autore | Du Lanying |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 online resource (274 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
animal model
animal models authentic virus camels cell-cell fusion combination complement Coronavirus coronavirus spike glycoprotein coronaviruses correlates of immunity cross-neutralization DPP4 Drivers fusion inhibitor HCoV-229E hDPP4 HKU4 host factors inflammation lipidomics mechanism of action MERS-coronavirus MERS-CoV MERS-CoV nucleocapsid protein Middle East respiratory syndrome coronavirus Middle East Respiratory Syndrome Virus mouse model murine CD8+ T cell epitope mutation MVA vaccine n/a nanobodies neutralizing antibody neutralizing monoclonal antibodies One Health pathogenesis peptide prevention and treatment pseudotyped virus pyroptosis Qatar rabbits RBD receptor-binding domain SARS-CoV severe acute respiratory syndrome coronavirus small-molecule inhibitor spike protein spike proteins therapeutic antibodies therapeutics transmission UHPLC-MS vaccine platforms vaccines |
| ISBN | 3-03921-851-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367737603321 |
Du Lanying
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||